Skip to main content

Establishment profile

BAYER HEALTHCARE PHARMACEUTICALS

100 BAYER BLVD. PO BOX 915, WHIPPANY, NJ, 07981
551114Corporate, Subsidiary, and Regional Managing Offices

Download as PDF →

OSHA inspections
1
over 11 years
Violations
0
Penalties
$0
Accident investigations on record
1 National Emphasis Program inspections

Summary

BAYER HEALTHCARE PHARMACEUTICALS has accumulated 0 OSHA violations across 1 inspection over 11 years of recorded history.

The most recent federal enforcement activity was recorded 11 years ago.

Federal records were found in 3 of 15 sources. Sources without matching records returned empty for this establishment.

Agency coverage

BAYER HEALTHCARE PHARMACEUTICALS appears in OSHA workplace safety, OFLC visa and labor certification (historical), and CPSC product recalls records only. No matching records were found in WHD wage enforcement, MSHA mine safety, EPA environmental compliance, NLRB labor relations, FMCSA motor carrier registration, SAM.gov federal debarment, CMS nursing home enforcement, or NHTSA vehicle recalls.

OSHA workplace safety

Inspections
1
0.1 / yr · last 11 yrs
Violations
0
0.0 / yr
Penalties
$0
Inspection trigger · planned
1 of 1

Peer comparison

0th

Fewer violations than most other employers in NAICS 5511 within NJ. Peer group: 28 employers. This establishment has 0 OSHA violations; peer median is 1.

Fewer violationsMore violations
Penalty percentile
0th
peer median: $1,000
Inspection frequency
0th
peer median: 1

Safety self-report (OSHA 300A)

No self-reported injury rates filed with OSHA's Injury Tracking Application for BAYER HEALTHCARE PHARMACEUTICALS. Verify directly with OSHA Injury Tracking Application

Industry benchmark

Industry avg TRIR
0.5
BLS SOII 2024
Industry avg DART
0.3
BLS SOII 2024
Self-reported TRIR
Not in OSHA ITA

BLS rates reflect industry-wide averages. Self-reported figures come from OSHA’s Injury Tracking Application; absence of self-reported data does not necessarily indicate non-compliance — many establishments fall below the ITA reporting threshold.

Inspection breakdown

Planned
1

Complaint- and accident-triggered inspections are stronger risk signals than routine planned inspections.

OSHA severe injury reports

No severe injury reports (hospitalization, amputation, or loss of an eye) on file under 29 CFR 1904.39 for BAYER HEALTHCARE PHARMACEUTICALS. Verify directly with Occupational Safety and Health Administration

Activity timeline

Data refreshed
Weekly
First OSHA inspection
Most recent activity
11 years ago

No federal enforcement activity has been recorded against this establishment in 11+ years. Most recent activity: 11 years ago. Data on this page is refreshed weekly.

Wage & Hour Division (WHD)

No WHD wage, overtime, or child-labor enforcement cases on file for BAYER HEALTHCARE PHARMACEUTICALS. Verify directly with Wage and Hour Division

Mine safety (MSHA)

No MSHA mine safety violations on file for BAYER HEALTHCARE PHARMACEUTICALS. Verify directly with Mine Safety and Health Administration

Labor relations (NLRB)

No NLRB unfair labor practice charges or union representation cases on file for BAYER HEALTHCARE PHARMACEUTICALS. Verify directly with National Labor Relations Board

Visa & labor certification (OFLC) — historical

Total applications
9
Certified
8
Avg wage ratio
1.60x
H-1B

Office of Foreign Labor Certification — labor condition applications for H-1B, H-2A, H-2B visa programs. Wage ratio = offered / prevailing wage. Historical data only: DOL ended OFLC Performance Data Disclosure publication in 2026, so the figures above reflect filings through the last ingested cycle and are not being refreshed. Treat as a historical snapshot, not a current signal.

Environmental compliance (EPA)

No EPA inspections or formal enforcement actions on file for BAYER HEALTHCARE PHARMACEUTICALS. Verify directly with Environmental Protection Agency

CPSC product recalls

Total recalls
1
Last 5 years
1
Last 12 months
1
Units recalled
0

Top hazard: The 6 mL nasal sprays contain an imidazoline, which must be in child-resistant packaging or meet the labeling requirements for non-complying packaging, as required by the Poison Prevention Packaging Act. The 6 mL nasal spray's packaging is not child-resistant nor bears the required labeling statement, posing a risk of serious injury or illness from poisoning, if the contents are swallowed by young children.. Most recent recall: 2026-04-30. Source: Consumer Product Safety Commission, matched on company name.

Federal contracts

This location

Obligated (5-yr)
$24.8M
Obligated (all-time)
$50.1M
Awards
564
Top agency
Department of Veterans Affairs
$25.0M
Company-wide — BAYER AG (across 2 entities)
Obligated (5-yr)
$25.4M
Obligated (all-time)
$26.6M
Awards (all-time)
112

Consolidated across all USAspending recipient entities under this corporate parent — not attributable to this single location.

Top agencies by obligation (this location)
Department of Veterans Affairs$25.0M
Department of Health and Human Services$21.9M
Department of Justice$2.0M
Department of Defense$1.3M

Federal contract dollars to this establishment. Primary NAICS: 325412 - PHARMACEUTICAL PREPARATION MANUFACTURING. Last action: 2026-06-30. Source: USAspending.gov, net obligations. Recipient address is the SAM registration / HQ address, not necessarily the worksite.

Inspection history

DateTriggerViolationsSeriousPenalty
2015-06-08Planned0$0

Source: OSHA IMIS. Citation amounts reflect initially assessed penalties; final amounts after appeal may differ.

In the news

Other employers in this industry and state

Other employers in corporate, subsidiary, and regional managing offices within NJ, ordered by federal enforcement volume:

Related searches

About this data

This profile aggregates federal enforcement records on BAYER HEALTHCARE PHARMACEUTICALS from every major federal compliance and enforcement source. OSHA workplace safety inspections, WHD wage cases, MSHA mine safety, EPA environmental enforcement, NLRB labor relations, OFLC visa/labor certification, FMCSA motor carrier registration, SAM.gov debarments, CMS nursing-home records, BLS industry safety benchmarks, OSHA ITA self-reported injury rates, SEC enforcement and financial disclosures, CPSC and NHTSA recalls.

Establishments are matched across agencies using normalized employer name, state, and ZIP code.

OSHA citations typically appear 3–8 months after the inspection, so very recent enforcement actions may not yet be reflected. Profiles may be incomplete if the establishment operates under multiple legal names or files under variations our entity-matching rules don’t yet cover. To report a missing record or correction, email corrections@fastdol.com.

Need API access, bulk download, or licensed redistribution? The website is free. Programmatic and licensed access is handled separately.

Contact sales →

Frequently asked

What is BAYER HEALTHCARE PHARMACEUTICALS's OSHA violation history?
BAYER HEALTHCARE PHARMACEUTICALS has 1 OSHA inspection on record with 0 violations and $0 in total penalties.
How does BAYER HEALTHCARE PHARMACEUTICALS's safety record compare to its industry?
BAYER HEALTHCARE PHARMACEUTICALS operates in the corporate, subsidiary, and regional managing offices industry. The industry average Total Recordable Incident Rate (TRIR) is 0.5.